cGAS-STING pathway activation drives inflammation, fibrosis, and podocyte injury in various kidney diseases
New research identifies a key pathway in kidney disease progression
This systematic review synthesizes preclinical data on the cGAS-STING signaling pathway's role in acute kidney injury, chronic kidney diseas…
A specific signaling pathway called cGAS-STING acts as a central hub, linking inflammation and metabolism to several types of serious kidney…
Immune checkpoint inhibitors in rectal cancer: balancing anti-tumor effects against ICI-associated colorectal injury
Immune drugs for rectal cancer can cause intestinal damage
This systematic review examines immune checkpoint inhibitors (ICIs) in rectal cancer, highlighting robust anti-tumor effects in dMMR/MSI-H t…
New research explores how specific proteins in the gut help manage side effects from immune checkpoint inhibitors used to treat rectal cance…
Elevated pretreatment pan-immune-inflammation value correlates with worse survival outcomes in patients treated with immune checkpoint inhibitors
High inflammation levels may signal poorer survival for cancer patients
This systematic review and meta-analysis of 3,272 participants across 28 cohorts found that elevated pretreatment PIV is associated with sho…
A new look at cancer data suggests that high inflammation scores before treatment can predict shorter survival for those using immune checkp…
Immune checkpoint inhibitors show limited activity in unselected pancreatic ductal adenocarcinoma without specific biomarkers
New Strategies Target Immune Therapies for Pancreatic Cancer
This mini review examines the role of immune checkpoint blockade, vaccines, and cellular therapies in recurrent pancreatic ductal adenocarci…
New research highlights specific ways to better select patients for immune checkpoint inhibitors and advanced cell therapies in pancreatic c…
Neoadjuvant immune checkpoint inhibitors plus chemotherapy increase pathological complete response in early-stage triple-negative breast cancer
Immune checkpoint inhibitors improve response in triple-negative breast cancer
This meta-analysis of 3,377 patients found that neoadjuvant immune checkpoint inhibitors combined with chemotherapy significantly increased …
Adding immune checkpoint inhibitors to chemotherapy helps more patients with early-stage triple-negative breast cancer achieve a complete re…
First-line immune checkpoint inhibitor combinations improve overall survival in extensive-stage small-cell lung cancer
Immune checkpoint inhibitors combined with chemotherapy improve small cell lung cancer survival
This meta-analysis of 3,910 patients with extensive-stage small-cell lung cancer (ES-SCLC) found that first-line immune checkpoint inhibitor…
Combining immune checkpoint inhibitors with chemotherapy shows better survival rates for patients with extensive stage small cell lung cance…
Natural polysaccharides combined with immune checkpoint inhibitors show synergistic benefits in preclinical and early clinical observations
Natural sugars may help patients whose cancer resists immune drugs
This systematic review examines the use of natural polysaccharides as immune adjuvants for patients with solid tumors resistant to immune ch…
New research explores how natural polysaccharides can help boost the effectiveness of immunotherapy for patients with advanced solid tumors.
Chemokine networks regulate triple-negative breast cancer tumor microenvironment but clinical translation remains limited
Chemokine Targets Show Promise in Lab but Face Clinical Hurdles
This systematic review examines the role of chemokine networks and targeted interventions in the triple-negative breast cancer immune microe…
New research highlights the role of chemokine networks in breast cancer, showing strong results in labs despite challenges in current clinic…
CircRNAs act as signaling hubs for immune checkpoints and indicators of ICI response in lymphoma
CircRNAs May Help Predict Response to Lymphoma Immunotherapy
This systematic review examines the role of circRNAs, including EBV-encoded types, in immune evasion within lymphomas. The authors conclude …
New research suggests that specific molecules called circRNAs could help doctors predict how patients with lymphoma will respond to immune c…
Spatial immune niches provide a framework for understanding immunotherapy resistance in gastric cancer
Spatial Immune Niches May Help Explain Gastric Cancer Treatment Response
This narrative review synthesizes diverse data types to identify spatial immune niches as key determinants of immunotherapy response in gast…
New research into spatial immune niches suggests a way to better understand why some patients with gastric cancer respond to immunotherapy.
Pretreatment sarcopenia and low PNI are associated with worse survival in ICI-treated HNSCC
Muscle Loss and Nutrition Linked to Survival in Head Cancer
This meta-analysis evaluates the prognostic impact of CT-based sarcopenia and nutritional indices on overall survival in patients with recur…
Low muscle mass and poor nutritional status are linked to worse survival outcomes for patients with advanced head and neck cancer.
Immune checkpoint inhibitors show higher rates of high-grade immune-related adverse events in cervical cancer
Immune checkpoint inhibitors show specific safety risks in cervical cancer
This meta-analysis of 3302 patients with cervical cancer evaluated the safety profile of immune checkpoint inhibitors (ICIs) compared to sta…
New analysis shows that while some side effects of immune checkpoint inhibitors are similar to standard care, certain high grade immune reac…